Reviva Pharmaceuticals Ownership | Who Owns Reviva Pharmaceuticals?


OverviewChart

Reviva Pharmaceuticals Ownership Summary


Reviva Pharmaceuticals is owned by 41.39% institutional investors, 14.79% insiders, and 43.82% retail investors. Woodline partners lp is the largest institutional shareholder, holding 6.63% of RVPH shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.28% of its assets in Reviva Pharmaceuticals shares.

RVPH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockReviva Pharmaceuticals41.39%14.79%43.82%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Woodline partners lp1.59M6.63%$2.04M
Millennium management1.24M5.17%$1.59M
Vanguard group1.03M4.27%$1.31M
Schonfeld strategic advisors1.01M4.22%$1.30M
Parkman healthcare partners504.60K2.10%$645.89K
Geode capital management236.12K0.98%$302.29K
Colony group161.00K0.67%$206.00K
Polar asset management partners154.80K0.64%$198.14K
Ubs group132.44K0.55%$169.52K
Blackrock102.93K0.43%$131.75K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Parkman healthcare partners504.60K0.09%$645.89K
Emc capital management44.53K0.05%$81.00K
Woodline partners lp1.59M0.02%$2.04M
Nri wealth management lc12.38K0.02%$22.41M
Drive wealth management20.00K0.01%$36.20K
Schonfeld strategic advisors1.01M0.01%$1.30M
Polar asset management partners154.80K0.00%$198.14K
Pale fire capital se25.00K0.00%$32.00K
Sound income strategies30.00K0.00%$54.30K
Millennium management1.24M0.00%$1.59M

Top Buyers

HolderShares% AssetsChange
Woodline partners lp1.59M0.02%537.78K
Millennium management1.24M0.00%386.90K
Schonfeld strategic advisors1.01M0.01%187.19K
Ubs group132.44K-124.34K
Two sigma investments, lp31.07K0.00%31.07K

Top Sellers

HolderShares% AssetsChange
Sabby management---237.00K
Jpmorgan chase---38.66K
Marshall wace, llp---34.87K
Jane street group---30.09K
Susquehanna group, llp35.60K--18.70K

New Positions

HolderShares% AssetsChangeValue
Group one trading29.39K0.00%29.39K$37.62K
Drive wealth management20.00K0.01%20.00K$36.20K
Nri wealth management lc12.38K0.02%12.38K$22.41M
Ifp advisors4.90K0.00%4.90K$8.87K
Spire wealth management1.20K0.00%1.20K$2.17K

Sold Out

HolderChange
Qube research-50.00
Wells fargo & company/mn-175.00
Archer investment-500.00
Vontobel-14.00K
Jane street group-30.09K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2024375.71%9,947,22745.22%415.10%15-25.00%980.00%
Jun 30, 2024356.06%6,849,68722.89%285.30%2025.00%5-16.67%
Mar 31, 202433-28.26%5,573,8375.84%234.83%16-42.86%6-14.29%
Dec 31, 20234615.00%5,266,25697.73%2115.55%2847.37%7-22.22%
Sep 30, 20234033.33%2,663,3851.20%118.17%19-9350.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.06M2.28%129.34K
Vanguard Institutional Extnd Mkt Idx Tr312.30K0.67%-
Fidelity Extended Market Index165.82K0.36%19.91K
BlackRock Extended Equity Market K48.10K0.15%-20.00
iShares Micro-Cap ETF53.94K0.12%-
Extended Equity Market Fund K47.45K0.10%-653.00
Fidelity Total Market Index47.14K0.10%-
Fidelity Series Total Market Index34.76K0.07%-
Northern Trust Extended Eq Market Idx34.12K0.07%-
NT Ext Equity Mkt Idx Fd - L34.12K0.07%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 18, 2022Patel Purav-Buy$14.07K
Sep 30, 2022Narayan Prabhu Chief Financial OfficerBuy$83.00K
Sep 08, 2022VEDANTA PARTNERS, LLC-Buy$86.96
Sep 08, 2022VEDANTA PARTNERS, LLC-Buy$51.38
Sep 08, 2022VEDANTA PARTNERS, LLC-Buy$2.09M

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q3--
2023 Q4--
2023 Q2--
2022 Q41-

RVPH Ownership FAQ


Who Owns Reviva Pharmaceuticals?

Reviva Pharmaceuticals shareholders are primarily institutional investors at 41.39%, followed by 14.79% insiders and 43.82% retail investors. The average institutional ownership in Reviva Pharmaceuticals's industry, Biotech Stocks , is 109.70%, which Reviva Pharmaceuticals falls below.

Who owns the most shares of Reviva Pharmaceuticals?

Reviva Pharmaceuticals’s largest shareholders are Woodline partners lp (1.59M shares, 6.63%), Millennium management (1.24M shares, 5.17%), and Vanguard group (1.03M shares, 4.27%). Together, they hold 16.06% of Reviva Pharmaceuticals’s total shares outstanding.

Does Blackrock own Reviva Pharmaceuticals?

Yes, BlackRock owns 0.43% of Reviva Pharmaceuticals, totaling 102.93K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 131.75K$. In the last quarter, BlackRock increased its holdings by 11.07K shares, a 12.05% change.

Who is Reviva Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Parkman healthcare partners is Reviva Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.09% of its assets in 504.6K Reviva Pharmaceuticals shares, valued at 645.89K$.

Who is the top mutual fund holder of Reviva Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Reviva Pharmaceuticals shares, with 2.28% of its total shares outstanding invested in 1.06M Reviva Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools